SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026892
Filing Date
2018-11-05
Accepted
2018-11-05 17:01:45
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20180930.htm 10-Q 1956538
2 EX-31.1 sndx-ex311_9.htm EX-31.1 10288
3 EX-31.2 sndx-ex312_8.htm EX-31.2 10736
4 EX-32.1 sndx-ex321_7.htm EX-32.1 11887
  Complete submission text file 0001564590-18-026892.txt   6878288

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sndx-20180930.xml EX-101.INS 1598127
6 XBRL TAXONOMY EXTENSION SCHEMA sndx-20180930.xsd EX-101.SCH 45539
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20180930_cal.xml EX-101.CAL 40997
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20180930_def.xml EX-101.DEF 151290
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20180930_lab.xml EX-101.LAB 301528
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20180930_pre.xml EX-101.PRE 255967
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 181160603
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences